PPT-NCDC PROGRAMMES Antimicrobial Resistance Containment

Antimicrobial resistance is a serious public health threat Contributory factors Inappropriate use overuse underuse and misuse of antimicrobials in clinical medicine use of antibiotics as growth promoters in animals. N. gonorrhoeae. . A Review. INTRODUCTION. Progressive antimicrobial resistance in . Neisseria gonorrhoeae . is an emerging public health threat. The Public Health Agency of Canada (the Agency) released updated recommendations in July 2013 for the diagnosis, treatment, follow-up and reporting of gonorrhea. Dr. Rachel Levine. Pennsylvania Physician General . Antimicrobial Resistance (AMR). Antimicrobial resistance (AMR) is the change in microbes (e.g. bacteria, parasites and fungi) which enable them to withstand treatment by antimicrobial drugs, meaning that the drugs no longer work, or work less effectively. Cody Loveland, MPH. Wyoming Department of Health. Outline . Overview of CDC Guidance. Containment Strategy. Epidemiology of . Antibiotic Resistance . in . Wyoming. Antibiotic Resistance Laboratory Network. Regulations. An Environment of Change. Brian Lubbers, DVM, PhD, . DACVCP. Director of Clinical Microbiology. Changing Regulations. Cephalosporin . Extralabel. Use Restriction. FDA Guidance 209. FDA Guidance 213. a pharmaceutical industry perspective. 17. th. November 2018. Dr Bryan Deane. Dept of Research, Medical & Innovation . Introduction – the ABPI; the biopharmaceutical industry. AMR: the issue. Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . Antibiotics. Antimicrobial drugs naturally produced by microorganisms. Penicillium. . species: . Penicillins. Cephalosporium. . specis. : . cephalosporins. Streptomyces. . species:. . lincosamides. Dr. Rachel Levine. Pennsylvania Physician General . Antimicrobial Resistance (AMR). Antimicrobial resistance (AMR) is the change in microbes (e.g. bacteria, parasites and fungi) which enable them to withstand treatment by antimicrobial drugs, meaning that the drugs no longer work, or work less effectively. Therapy. The development of antimicrobial drugs represents one of the most important advances in therapeutics, both in the control or cure of serious infections and in the prevention and treatment of infectious complications of other therapeutic modalities such as cancer chemotherapy, immunosuppression, and surgery.. . MDR. was defined as acquired . non susceptibility. . to . at least one agent in three or . more antimicrobial . categories. ,. . XDR. was defined as . non susceptibility. . to . at least one agent in all but two or . Resistance : T ackling a crisis for the health and wealth of nations The Review on Antimicrobial Resistance Chaired by Jim O’Neill December 2014 Contents What is antimicrobial resistance? Dmitry Makarov. Department of Feed and Feed Additives safety . . ANTIMICROBIAL RESISTANCE (AMR) IS A GLOBAL THREAT TO MANKIND. *. World Health Organization , author. Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO. Ter . gelegenheid. van . het. . emeritaat. . van Johanna Fink-. gremmels. Utrecht, NL. 10 . july. 2014. P.L. . Toutain. National Veterinary School of Toulouse, France. The priorities of a sustainable veterinary antimicrobial therapy is related to public health issues, not to animal health issues. 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020.